| Document Date: 2013-07-12 14:26:36
Open Document File Size: 82,63 KBShare Result on Facebook
Company GlaxoSmithKline Inc. / FOREWORD Health Canada / Manufacturer/Sponsor GlaxoSmithKline Inc. / Health Canada GlaxoSmithKline Inc. / / Country Canada / / Currency USD / / Event FDA Phase / / IndustryTerm pharmaceutical development / drug product / gray butyl rubber / conventional pharmaceutical equipment / particular product / manufacturing / colourless solution / degradation products / chemical structure / food / manufacturing process / / MedicalCondition both aggressive cancers / solid tumours / lymphoblastic lymphoma / disease / tumour / T-cell lymphoblastic lymphoma / hypersensitivity / T-cell acute lymphoblastic leukemia / T-cell lymphoma / / MedicalTreatment chemotherapy / / Organization Health Products and Food Branch / / Position General Information Nelarabine / / Product Sodium chloride / nelarabine / SBD / Hydrochloric acid / Atriance / / PublishedMedium the Health Canada review / / Technology Pharmacokinetics / DNA synthesis / chemotherapy / Pharmacodynamics / stem cells / /
SocialTag |
Summary Basis of Decision Atriance